Rigorous R&D for Heart Disease Treatments to Drive the Global Coronary Stents Market

The Global Coronary Stents Market is expecting around 6.9% CAGR during 2022-27, cites MarkNtel Advisors in their recent research report. The increasing elderly population with different cardiovascular diseases due to hypertension, fluctuating eating habits, & changing living standards is the prime aspect propelling the demand for treatments like coronary stents worldwide.

Besides, the growing focus of governments of different countries on strengthening their respective healthcare sectors, i.e., portraying massive financial support & initiatives like research & development to advance the treatments, is also augmenting the market growth. 

Moreover, the increasing population of people suffering from obesity, where the body begins accumulating abnormal amounts of fat in arteries & causes multiple health problems like coronary heart disease, is another prominent aspect accelerating the demand for coronary stents to address such issues and driving the global market, further states the research report, “Global Coronary Stents Market Analysis, 2022.”

Reduced Possibilities of Heart Attacks using Drug-Eluting Stents to Boost the Global Market

Drug-Eluting stents are coated in a layer of slow-release medicine and help prevent blood clots and reopen the arteries. The growing awareness among people about these advantages is the prime aspect projected to lead these stents to dominate the market with the largest share during 2022-27.

Besides, drug-eluting stents also promote reduced possibilities of heart attacks & future blockage, i.e., another crucial aspect escalating their demand among people across different countries worldwide and augmenting the overall market growth.

With Rapidly Increasing Obese Population, North America to Dominate the Market through 2027

North America is experiencing a prominent portion of its population suffering from obesity, i.e., surging the need for treatments for coronary heart diseases. As a result, the demand for coronary stents is escalating swiftly and playing a crucial role in augmenting the overall market expansion across the region. 

Besides, the growing focus of governments of different countries on expanding their healthcare sectors, i.e., displaying massive investments and R&D activities to enhance the treatment for coronary heart diseases, is another prominent aspect projected to drive the regional market over the forecast years, reveals MarkNtel Advisors in their research report, "Global Coronary Stents Market Analysis, 2022."

Competitive Landscape

The leading players in the Global Coronary Stents Market are Abbott Laboratories, Inc., AMG International GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, B. Braun Melsungen AG, Cook Medical, Inc., Medtronic, Inc., MicroPort Scientific Corporation, Stentys SA, and Terumo Corporation.

Key Questions Answered in the Research Report

1. What are the current & future trends in the Global Coronary Stents Market?
2. How has the industry been evolving in terms of geography & product adoption?
3. How has the competition been shaping across various countries, followed by their comparative factorial indexing?
4. What are the key growth drivers & challenges for the Global Coronary Stents Market?
5. What are the customer orientation, purchase behavior, & expectations from coronary stents manufacturers across various regions?

Market Segmentation:

1. By Stent Type (Drug-Eluting Stent (Biodegradable, Non-Biodegradable), Bioresorbable Stent, Bare Metal Stent, Covered Stent)
2. By Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, Natural Biomaterial)
3. By Deployment (Self-Expandable, Balloon-Expandable)
4. By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others (Cardiac Catheterization Laboratories, etc.))
5. By Region (North America, Latin America, Europe, Middle East & Africa, Asia-Pacific)
6. By Countries (The US, Canada, Brazil, Mexico, Australia, The UK, Germany, France, Italy, Spain, South Africa, GCC, China, Japan, India, Australia, South East Asia)
7. By Companies (Abbott Laboratories, Inc., AMG International GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, B. Braun Melsungen AG, Cook Medical, Inc., Medtronic, Inc., MicroPort Scientific Corporation, Stentys SA, Terumo Corporation)